Specific Biologics
Latest round
- Series A
Last raised
- Nov 2026
Total raised
- $35M
Investors
- 9
About Specific Biologics
Founded in 2017 in Toronto, Canada, Specific Biologics Inc. develops advanced gene editing solutions utilizing its Dualase platform.Specific Biologics Inc. (SBI) specializes in developing innovative gene editing technologies, with a core focus on its proprietary platform known as Dualase. This technology employs a dual-cleaving nuclease that cuts DNA at two sites, generating non-compatible ends intended to improve the precision of genetic modifications. By leveraging the cell's natural DNA repair mechanisms, Dualase facilitates either defined length deletions or enhanced repair efficiency, allowing SBI to target genetic diseases previously deemed untreatable. The end users of this technology include researchers and clinicians in academic and industrial settings, with potential applications across a broad range of genetic disorders.Specific Biologics generates revenue through strategic partnerships and collaborations rather than direct consumer sales. The company engages with biotech firms, research institutions, and healthcare providers to license its gene editing technology, particularly the Dualase platform. These transactions take the form of licensing agreements, where clients pay fees for access to the technology, potentially structured as ongoing royalties based on the success of clinical applications.In October 2023, Specific Biologics Inc. SBI is also planning to expand into North American and European markets, focusing on healthcare institutions and providers to enhance its reach.
Who invested in Specific Biologics
9 investors across 2 rounds
See all investors in Specific Biologics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Specific Biologics
Who invested in Specific Biologics?
Specific Biologics has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Specific Biologics raised?
Specific Biologics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Specific Biologics last raise money?
Specific Biologics's most recent round on record is a Series A, in Nov 2026.
What does Specific Biologics do?
Founded in 2017 in Toronto, Canada, Specific Biologics Inc.
Where is Specific Biologics headquartered?
Specific Biologics is headquartered in Toronto, Canada.
Which VCs invest in companies like Specific Biologics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Specific Biologics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Specific Biologics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.